Does Dr. YOMNA ABU-FARSAKH have financial conflicts of interest?

Dr. YOMNA ABU-FARSAKH (MD) has received a total of $1,330 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,330 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. YOMNA ABU-FARSAKH?

According to CMS Open Payments data, Dr. YOMNA ABU-FARSAKH received funding from DAIICHI SANKYO ($127), SOBI ($124), and NOVARTIS PHARMACEUTICALS CORPORATION ($92).

Does Dr. YOMNA ABU-FARSAKH receive research grants or speaking fees?

Dr. YOMNA ABU-FARSAKH has received $1,330 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. YOMNA ABU-FARSAKH

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: NORTH CANTON, OH 44720

NPI Number: 1780146365

LIFETIME INDUSTRY VALUE

$1,330

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABU-FARSAKH is a verified Internal Medicine practitioner based in NORTH CANTON, OH.

Between 2021 and 2025, Dr. ABU-FARSAKH had an overall industry promotional and research financial footprint of $1,330 as recorded in the federal CMS Open Payments database.

$1,330 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU-FARSAKH's primary funding source is DAIICHI SANKYO, which accounts for $127 (representing 9.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

DAIICHI SANKYO

Rank 1

$127

9.6%

SOBI

Rank 2

$124

9.4%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$92

6.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.